Literature DB >> 485130

New rapid assay for nafcillin in serum by spectrofluorometry.

D M Lichtenwalner, B Suh, B Lorber, A M Sugar.   

Abstract

A new, rapid method for measuring serum levels of nafcillin by spectrofluorometry is described. The method involves extraction of 2 ml of acidified serum with n-butyl chloride, subjecting the organic solvent layer to excitation at 340 nm, and measuring the relative intensity of emission fluorescence at 380 nm. An excellent linear correlation exists between serum levels of nafcillin and the relative intensity in a drug concentration range of 0.25 to 150 mug/ml. The results obtained by this spectrofluorometric technique are in complete accord with those obtained by the conventional microbiological assay using Staphylococcus aureus ATCC 6538P. The method is not interfered with by elevated levels of endogenous metabolic products or the presence of other drugs, including a number of antimicrobial agents. The assay is interfered with, however, by the presence of salicylates, for which appropriate correction can easily be made. A salicylate assay employing a spectrofluorometric technique is also described.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 485130      PMCID: PMC352823          DOI: 10.1128/AAC.16.2.210

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Rapid determination of salicylate in biological fluids.

Authors:  P TRINDER
Journal:  Biochem J       Date:  1954-06       Impact factor: 3.857

2.  Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections.

Authors:  J G Kane; R H Parker; G W Jordan; P D Hoeprich
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

3.  Nafcillin entry into human cerebrospinal fluid.

Authors:  B E Fossieck; J G Kane; C R Diaz; R H Parker
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

4.  Pharmacokinetics of nafcillin in patients with renal failure.

Authors:  C R Diaz; J G Kane; R H Parker; F R Pelsor
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

5.  Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin.

Authors:  H Friedman; G H Warren
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

6.  Nafcillin treatment of Staphylococcus aureus meningitis.

Authors:  D E Ruiz; J F Warner
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

7.  Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections.

Authors:  L M Kancir; C U Tuazon; T A Cardella; J N Sheagren
Journal:  Arch Intern Med       Date:  1978-06
  7 in total
  2 in total

1.  Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants.

Authors:  B Suh; S J Wadsworth; D M Lichtenwalner
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometry.

Authors:  D M Lichtenwalner; B Suh; B Lorber; A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.